TYLE PRAVEEN

CIK 00012969365 companiesENCINITAS, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001296936

Recent Transactions

50 trades

Award
KIORA PHARMACEUTICALS INC$KPRX
Stock Option (right to buy)
2025-04-01+30,000→ 30,000 total
Purchase
KIORA PHARMACEUTICALS INC$KPRX
Common Stock
2024-08-19$3.96/sh+5,000→ 5,014 total
Award
KIORA PHARMACEUTICALS INC$KPRX
Stock Option (right to buy)
2024-07-01+1,778→ 1,778 total
Award
Skye Bioscience, Inc.$SKYE
Stock Option (Right to Buy)
2024-02-29+35,000→ 35,000 total
Award
Skye Bioscience, Inc.$SKYE
Stock Option (Right to Buy)
2023-11-06+14,110→ 20,001 total
Award
KIORA PHARMACEUTICALS INC$KPRX
Stock Option (right to buy)
2023-09-29+5,000→ 5,000 total
Award
Skye Bioscience, Inc.$SKYE
Stock Option (Right to Buy)
2023-08-25+1,472,692→ 1,472,692 total
Award
KIORA PHARMACEUTICALS INC$KPRX
Stock Option (right to buy)
2023-03-03+8,000→ 8,000 total
Award
Skye Bioscience, Inc.$SKYE
Stock Option (Right to Buy)
2023-01-05+250,000→ 250,000 total
Award
Skye Bioscience, Inc.$SKYE
Stock Option (Right to Buy)
2023-01-05+250,000→ 250,000 total
Award
KIORA PHARMACEUTICALS INC$KPRX
Stock Option (right to buy)
2022-02-01+5,000→ 5,000 total
Award
Skye Bioscience, Inc.$SKYE
Director Stock Option (Right to Buy)
2021-09-14+25,000→ 275,000 total
Award
Skye Bioscience, Inc.$SKYE
Director Option Grant (Right to Buy)
2021-07-22+250,000→ 250,000 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2021-02-28+9,727→ 82,061 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Restricted Stock Units
2021-02-28−28,690→ 57,380 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Restricted Stock Units
2021-02-28−9,727→ 0 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2021-02-28+28,690→ 137,351 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Restricted Stock Units
2021-02-28−2,990→ 0 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Restricted Stock Units
2021-02-28−26,600→ 26,600 total
Tax Payment
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2021-02-28$7.19/sh−16,560→ 120,791 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2021-02-28+2,990→ 72,334 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2021-02-28+26,600→ 108,661 total
Award
LEXICON PHARMACEUTICALS, INC.$LXRX
Stock Option (Right to Buy)
2021-02-11+96,310→ 96,310 total
Award
LEXICON PHARMACEUTICALS, INC.$LXRX
Restricted Stock Units
2021-02-11+32,100→ 32,100 total
Award
KIORA PHARMACEUTICALS INC$KPRX
Stock Option (right to buy)
2021-02-01+3,333→ 3,333 total
Award
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2020-04-22+19,893→ 74,188 total
Tax Payment
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2020-04-22$1.96/sh−4,844→ 69,344 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2020-02-28+2,990→ 17,969 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2020-02-28+26,600→ 54,295 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Restricted Stock Units
2020-02-28−2,990→ 2,990 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Restricted Stock Units
2020-02-28−26,600→ 53,200 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2020-02-28+9,726→ 27,695 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Restricted Stock Units
2020-02-28−9,726→ 9,727 total
Award
KIORA PHARMACEUTICALS INC$KPRX
Stock Option (right to buy)
2020-02-14+3,333→ 3,333 total
Award
LEXICON PHARMACEUTICALS, INC.$LXRX
Stock Option (Right to Buy)
2020-02-06+258,210→ 258,210 total
Award
LEXICON PHARMACEUTICALS, INC.$LXRX
Restricted Stock Units
2020-02-06+86,070→ 86,070 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Restricted Stock Units
2019-02-28−2,990→ 5,980 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2019-02-28+2,990→ 5,252 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2019-02-28+9,727→ 14,979 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Restricted Stock Units
2019-02-28−9,727→ 19,453 total
Award
LEXICON PHARMACEUTICALS, INC.$LXRX
Stock Option (Right to Buy)
2019-02-07+148,200→ 148,200 total
Award
LEXICON PHARMACEUTICALS, INC.$LXRX
Restricted Stock Units
2019-02-07+79,800→ 79,800 total
Award
KIORA PHARMACEUTICALS INC$KPRX
Stock Option (right to buy)
2019-02-01+50,000→ 50,000 total
Award
KIORA PHARMACEUTICALS INC$KPRX
Common Stock
2018-07-10+50,000→ 61,893 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Restricted Stock Units
2018-02-28−2,990→ 8,970 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2018-02-28+2,990→ 2,990 total
Tax Payment
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2018-02-28$8.53/sh−728→ 2,262 total
Award
LEXICON PHARMACEUTICALS, INC.$LXRX
Stock Option (Right to Buy)
2018-02-08+82,820→ 82,820 total
Award
LEXICON PHARMACEUTICALS, INC.$LXRX
Restricted Stock Units
2018-02-08+29,180→ 29,180 total
Award
KIORA PHARMACEUTICALS INC$KPRX
Stock Option (right to buy)
2017-06-21+15,000→ 15,000 total

Companies

Recent Filings

Address

C/O KIORA PHARMACEUTICALS, INC. 332 ENCINITAS BLVD., SUITE 102

ENCINITAS, CA, 92024

View on SEC.gov